Ramiro, S., Heijde, D. v. d., Deodhar, A., Baraliakos, X., Poddubnyy, D., Gensler, L. S., . . . Vaux, T. Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension. BMJ Publishing Group.
Chicago Style (17th ed.) CitationRamiro, Sofia, et al. Long-term Safety and Sustained Efficacy of Bimekizumab in Patients with Ankylosing Spondylitis (radiographic Axial Spondyloarthritis): 5-year Results from BE AGILE (phase 2b) and Its Open-label Extension. BMJ Publishing Group.
MLA (9th ed.) CitationRamiro, Sofia, et al. Long-term Safety and Sustained Efficacy of Bimekizumab in Patients with Ankylosing Spondylitis (radiographic Axial Spondyloarthritis): 5-year Results from BE AGILE (phase 2b) and Its Open-label Extension. BMJ Publishing Group.